Patent · US Active

Pharmaceutical compositions comprising silica microspheres

US10278917B2 · kind B2 · utility

6Cited by
18References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 2016
Grant dateMay 7, 2019
Priority date
Expiry dateOct 15, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.